183 related articles for article (PubMed ID: 18931027)
21. Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase.
Kanno S; Lee PC; Zhang Y; Ho C; Griffith BP; Shears LL; Billiar TR
Circulation; 2000 Jun; 101(23):2742-8. PubMed ID: 10851213
[TBL] [Abstract][Full Text] [Related]
22. Effects of quercetin on gene and protein expression of NOX and NOS after myocardial ischemia and reperfusion in rabbit.
Wan LL; Xia J; Ye D; Liu J; Chen J; Wang G
Cardiovasc Ther; 2009; 27(1):28-33. PubMed ID: 19207477
[TBL] [Abstract][Full Text] [Related]
23. Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart.
Salloum F; Yin C; Xi L; Kukreja RC
Circ Res; 2003 Apr; 92(6):595-7. PubMed ID: 12637371
[TBL] [Abstract][Full Text] [Related]
24. [Morphine-induced late cardioprotection: potential role of inducible nitric oxide synthase].
Shi EY; Jiang XJ; Bai H; Nakajima Y
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):891-5. PubMed ID: 15329271
[TBL] [Abstract][Full Text] [Related]
25. Pioglitazone attenuates myocardial ischemia-reperfusion injury via up-regulation of ERK and COX-2.
Wang H; Zhu QW; Ye P; Li ZB; Li Y; Cao ZL; Shen L
Biosci Trends; 2012 Dec; 6(6):325-32. PubMed ID: 23337792
[TBL] [Abstract][Full Text] [Related]
26. COX-2 mediates morphine-induced delayed cardioprotection via an iNOS-dependent mechanism.
Jiang X; Shi E; Nakajima Y; Sato S
Life Sci; 2006 Apr; 78(22):2543-9. PubMed ID: 16325209
[TBL] [Abstract][Full Text] [Related]
27. Exercise-induced late preconditioning in mice is triggered by eNOS-dependent generation of nitric oxide and activation of PKCε and is mediated by increased iNOS activity.
Guo Y; Li Q; Xuan YT; Wu WJ; Tan W; Slezak J; Zhu X; Tomlin A; Bolli R
Int J Cardiol; 2021 Oct; 340():68-78. PubMed ID: 34400167
[TBL] [Abstract][Full Text] [Related]
28. Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1.
Bulhak AA; Sjöquist PO; Xu CB; Edvinsson L; Pernow J
Basic Res Cardiol; 2006 May; 101(3):244-52. PubMed ID: 16411023
[TBL] [Abstract][Full Text] [Related]
29. Infarct size and nitric oxide synthase in murine myocardium.
Sumeray MS; Rees DD; Yellon DM
J Mol Cell Cardiol; 2000 Jan; 32(1):35-42. PubMed ID: 10652188
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
[TBL] [Abstract][Full Text] [Related]
31. Chronic treatment with ticagrelor limits myocardial infarct size: an adenosine and cyclooxygenase-2-dependent effect.
Nanhwan MK; Ling S; Kodakandla M; Nylander S; Ye Y; Birnbaum Y
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2078-85. PubMed ID: 25012137
[TBL] [Abstract][Full Text] [Related]
32. Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction.
Shimazu T; Otani H; Yoshioka K; Fujita M; Okazaki T; Iwasaka T
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2061-72. PubMed ID: 21890687
[TBL] [Abstract][Full Text] [Related]
33. Decreased tetrahydrobiopterin and disrupted association of Hsp90 with eNOS by hyperglycemia impair myocardial ischemic preconditioning.
Vladic N; Ge ZD; Leucker T; Brzezinska AK; Du JH; Shi Y; Warltier DC; Pratt PF; Kersten JR
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2130-9. PubMed ID: 21908789
[TBL] [Abstract][Full Text] [Related]
34. The Cardioprotective Effects of Late-Phase Remote Preconditioning of Trauma Depends on Neurogenic Pathways and the Activation of PKC and NF-κB (But Not iNOS) in Mice.
Song Y; Ye YJ; Li PW; Zhao YL; Miao Q; Hou DY; Ren XP
J Cardiovasc Pharmacol Ther; 2016 May; 21(3):310-9. PubMed ID: 26450997
[TBL] [Abstract][Full Text] [Related]
35. MK-954 (losartan potassium) exerts endothelial protective effects against reperfusion injury: evidence of an e-NOS mRNA overexpression after global ischemia.
Barsotti A; Di Napoli P; Taccardi AA; Spina R; Stuppia L; Palka G; Barbacane RC; De Caterina R; Conti P
Atherosclerosis; 2001 Mar; 155(1):53-9. PubMed ID: 11223426
[TBL] [Abstract][Full Text] [Related]
36. Myocardial ischemia/reperfusion injury in the inducible nitric oxide synthase knockout mice.
Xi L; Jarrett NC; Hess ML; Kukreja RC
Life Sci; 1999; 65(9):935-45. PubMed ID: 10465353
[TBL] [Abstract][Full Text] [Related]
37. Differential response to myocardial reperfusion injury in eNOS-deficient mice.
Sharp BR; Jones SP; Rimmer DM; Lefer DJ
Am J Physiol Heart Circ Physiol; 2002 Jun; 282(6):H2422-6. PubMed ID: 12003854
[TBL] [Abstract][Full Text] [Related]
38. Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium.
Hamid SA; Bower HS; Baxter GF
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2598-606. PubMed ID: 17220176
[TBL] [Abstract][Full Text] [Related]
39. Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury.
Wildhirt SM; Weismueller S; Schulze C; Conrad N; Kornberg A; Reichart B
Cardiovasc Res; 1999 Aug; 43(3):698-711. PubMed ID: 10690341
[TBL] [Abstract][Full Text] [Related]
40. Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-kappaB dependent pathway.
Li Q; Guo Y; Tan W; Ou Q; Wu WJ; Sturza D; Dawn B; Hunt G; Cui C; Bolli R
Circulation; 2007 Oct; 116(14):1577-84. PubMed ID: 17785622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
